Gangliosidoses clinical trials
The registry lists 11 studies for Gangliosidoses across 7 countries. 5 are recruiting or about to start. 3 of them are mainly about Gangliosidoses (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-21. Counting its 4 narrower conditions too, such as Gangliosidoses, GM2: 50 studies, 14 open.
Get an email when these change. Save the Gangliosidoses studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University of Minnesota (3) · Children's Hospital of Philadelphia (2) · SphinCS Lyso Gemeinnutzige UG (Haftungsbeschrankt) (1) · Sun Yat-sen University (1) · National Human Genome Research Institute (NHGRI) (1) · Assistance Publique - Hôpitaux de Paris (1) · Lysosomal and Rare Disorders Research and Treatment Center, Inc. (1) · CENTOGENE GmbH Rostock (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Mar 2027A Natural History Study of the Gangliosidoses · University of Minnesota
Who these studies take
Of the 4 Gangliosidoses studies recruiting now, 3 (75%) set no upper age limit and 1 (25%) stop at 75 or younger. 4 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 4 (100%) | 4 (100%) |
| 18 | 3 (75%) | 3 (75%) |
| 30 | 3 (75%) | 3 (75%) |
| 40 | 3 (75%) | 3 (75%) |
| 50 | 3 (75%) | 3 (75%) |
| 65 | 3 (75%) | 3 (75%) |
| 75 | 3 (75%) | 3 (75%) |
| 85 | 3 (75%) | 3 (75%) |
Across all 11 studies, recruiting or not: 36% stop at 75 or younger and 27% at 65; 91% take children; 0% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 11 of 11. search them.
- A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 GangliosidosisRecruitingNCT03952637Phase 1/21 country
- Translational Potential of ex Vivo Gene Therapy in GM2 GangliosidosisNot yet recruitingNCT074454901 country
- A Natural History Study of the GangliosidosesRecruitingNCT006681871 country
- The Myelin Disorders Biorepository ProjectRecruitingNCT030473691 country
- Registry GangliosidosesRecruitingNCT046247891 country
- LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for LeukodystrophiesCompletedNCT026991901 country
- GM1 Prophylaxis for WBRT Related Cognitive DysfunctionTerminatedNCT04395339Phase 31 country
- Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)WithdrawnNCT022986474 countries
- Synergistic Enteral Regimen for Treatment of the GangliosidosesTerminatedNCT02030015Phase 41 country
- Screening of Lysosomal Storage Disorders Diseases in Minority GroupsStatus unknownNCT038120421 country
- Gene Therapy for Tay-Sachs DiseaseCompletedNCT018692701 country